Skip to content

Thoracoscopic radical resection of lung cancer in local and regional hospitals based on ERAS concept: A prospective randomized controlled clinical trial

Perioperative study of thoracoscopic radical resection of lung cancer in local and regional hospitals based on ERAS concept

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084551
Enrollment
Unknown
Registered
2024-05-20
Start date
2021-08-15
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

ERAS group:Admission to ERAS mission
Preoperative preparation for respiratory and cardiopulmonary exercises
Oral carbohydrates on the morning of surgery
Risk assessment and prevention of thrombosis
Preventive analgesia
Prophylactic antibiotic therapy
Optimization of anesthesia mode
Optimization of operation methods
The indwelling optimization of drainage tube
Prevent hypothermia
Target-directed rehydration
Get out of bed as soon as possible after surgery
Start eating early after surgery
Drainage tube early removal
Restricted intravenous fluids
conventional rehabilitation group:Only traditional education and preoperative preparation, intraoperative anesthesia operations, and postoperative traditional rehabilitation treatment models are adopt

Sponsors

The People's Hospital of Rongchang District, Chongqing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients undergoing radical resection for lung cancer in our department between August , 2021, and July ,2022. (1) The age range was 18 to 70 years old; Agreed to enter the ERAS program; (2) No neoadjuvant therapy such as radiotherapy or chemotherapy was received before operation; (3) The clinical stage before operation was stage I and stage II; (4) The cardiopulmonary function was assessed to be able to tolerate single lung ventilation and lobectomy

Exclusion criteria

Exclusion criteria: ? Tumor locally invaded adjacent organs, extensive adhesion of pleura; Previous history of pulmonary tuberculosis and pleurisy ? History of other malignant tumors; Patients with hyperplasia of the prostate ? Anesthesia risk score (ASA) > 3 points

Design outcomes

Primary

MeasureTime frame
total length of hospital stay;postoperative length of stay;time of thoracic drainage tube removal;time of first postoperative movement out of bed;time of first postoperative eating;early postoperative pain score;hospitalization cost;

Secondary

MeasureTime frame
postoperative atelectasis/pulmonary infection;postoperative bleeding;arrhythmia;hoarseness;chronic air leakage;incision infection/incisiondehiscence;respiratory failure;postoperative VTE;chylothorax;The incidence of postoperative ICU admission;postoperative chest tube replacement rate;mortality within 30 days after surgery;Operative time ;Blood loss;

Countries

China

Contacts

Public ContactYingkai Chen

People's Hospital of Rongchang District, Chongqing, China

834812478@qq.com+86 185 8020 0835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026